Latest Regenerative January 24, 2026 News

Cyto-Facto to Manufacture Steminent’s Stem Cell Therapy for Spinocerebellar Ataxia, Seeking Conditional Approval in Japan

Stemchymal's CDMO has been selected, while the company seeks conditional approval in both Japan and Taiwan following Phase II results.

Resbiomed, a placental collagen materials manufacturer, is working on scaling up production for what appears regenerative ophthalmology in Europe.